Oncolytic virotherapy for multiple myeloma: past, present, and future.
about
Clinical use of proteasome inhibitors in the treatment of multiple myelomaCurative one-shot systemic virotherapy in murine myeloma.Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.Crocin Suppresses Constitutively Active STAT3 Through Induction of Protein Tyrosine Phosphatase SHP-1.
P2860
Oncolytic virotherapy for multiple myeloma: past, present, and future.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oncolytic virotherapy for multiple myeloma: past, present, and future.
@en
type
label
Oncolytic virotherapy for multiple myeloma: past, present, and future.
@en
prefLabel
Oncolytic virotherapy for multiple myeloma: past, present, and future.
@en
P2860
P356
P1433
P1476
Oncolytic virotherapy for multiple myeloma: past, present, and future.
@en
P2093
Chandini M Thirukkumaran
Don G Morris
P2860
P304
P356
10.1155/2011/632948
P577
2011-05-10T00:00:00Z